JPMorgan Chase & Co’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-72,764
| Closed | -$2.54M | – | 6704 |
|
|
2024
Q1 | $2.54M | Buy |
72,764
+21,238
| +41% | +$742K | ﹤0.01% | 2999 |
|
|
2023
Q4 | $1.96M | Sell |
51,526
-318,459
| -86% | -$12.1M | ﹤0.01% | 3153 |
|
|
2023
Q3 | $6.79M | Buy |
369,985
+3,088
| +0.8% | +$56.7K | ﹤0.01% | 2241 |
|
|
2023
Q2 | $9.52M | Buy |
366,897
+326,919
| +818% | +$8.49M | ﹤0.01% | 2068 |
|
|
2023
Q1 | $754K | Buy |
39,978
+7,707
| +24% | +$145K | ﹤0.01% | 3609 |
|
|
2022
Q4 | $795K | Buy |
32,271
+3,448
| +12% | +$84.9K | ﹤0.01% | 3495 |
|
|
2022
Q3 | $517K | Buy |
28,823
+3,488
| +14% | +$62.6K | ﹤0.01% | 3728 |
|
|
2022
Q2 | $288K | Buy |
25,335
+1,721
| +7% | +$19.6K | ﹤0.01% | 4160 |
|
|
2022
Q1 | $527K | Sell |
23,614
-37,702
| -61% | -$841K | ﹤0.01% | 3968 |
|
|
2021
Q4 | $2.68M | Buy |
61,316
+36,905
| +151% | +$1.61M | ﹤0.01% | 3027 |
|
|
2021
Q3 | $813K | Sell |
24,411
-5,370
| -18% | -$179K | ﹤0.01% | 3723 |
|
|
2021
Q2 | $820K | Buy |
29,781
+11,084
| +59% | +$305K | ﹤0.01% | 3742 |
|
|
2021
Q1 | $375K | Sell |
18,697
-3,787
| -17% | -$76K | ﹤0.01% | 4192 |
|
|
2020
Q4 | $742K | Buy |
+22,484
| New | +$742K | ﹤0.01% | 3532 |
|